Abstract
New arylsulfanyl pyrazolylpyrazoline derivatives were synthesized via a facile protocol, and their structure was confirmed by FT-IR, 1H and 13C NMR, and mass spectra. Some of the synthesized compounds exhibited remarkable in vitro antitubercular activity. Molecular docking study provided well-clustered solutions to the mode of binding and affinity of these molecules to the active site of MTB enoyl–acyl carrier protein reductase (InhA).
Similar content being viewed by others
REFERENCES
Vergelli, C., Cilibrizzi, A., Crocetti, L., Graziano, A., Piaz, V.D., Wan, B., Wang, Y., Franzblau, S., and Giovannoni, M.P., Drug Dev. Res., 2013, vol. 74, p. 162. https://doi.org/10.1002/ddr.21057
Johnson, R., Streicher, E.M., Louw, G.E., Warren, R.M., Van Helden, P.D., and Victor, T., Curr. Issues Mol. Biol., 2006, vol. 8, no. 2, p. 97. https://doi.org/10.21775/cimb.008.097
Lienhardt, C., Vernon, A., and Raviglione, M.C., Curr. Opin. Pulm. Med., 2010, vol. 16, no. 3, p. 186. https://doi.org/10.1097/MCP.0b013e328337580c
Sankar, M.M., Singh, J., Diana, S.C., and Singh, S., Tuberculosis, 2013, vol. 93, no. 1, p. 75. https://doi.org/10.1016/j.tube.2012.10.005
Global Tuberculosis Report 2019. World Health Organization. https://www.who.int/publications/i/item/9789241565714.AccessedSep5,2021
Zhang, T., Dong, M., Zhao, J., Zhang, X., and Mei, X., J. Pestic. Sci., 2019, vol. 44, no. 3, p. 181. https://doi.org/10.1584/jpestics.D19-028
Mishra, V.K., Mishra, M., Kashaw, V., and Kashaw, S.K., Bioorg. Med. Chem., 2017, vol. 25, no. 6, p. 1949. https://doi.org/10.1016/j.bmc.2017.02.025
Kumar, G., Tanwar, O., Kumar, J., Akhter, M., Sharma, S., Pillai, C.R., Alam, M.M., and Zama, M.S., Eur. J. Med. Chem., 2018, vol. 149, p. 139. https://doi.org/10.1016/j.ejmech.2018.01.082
Acharya, B.N., Saraswat, D., Tiwari, M., Shrivastava, A.K., Ghorpade, R., Bapna, S., and Kaushik, M.P., Eur. J. Med. Chem., 2010, vol. 45, no. 2, p. 430. https://doi.org/10.1016/j.ejmech.2009.10.023
Matiadis, D. and Sagnou, M.A., Int. J. Mol. Sci., 2020, vol. 21, no. 15, article no. 5507. https://doi.org/10.3390/ijms21155507
Özdemir, A., Altintop, M.D., Kaplancıklı, Z.A., Turan-Zitouni, G., Karaca, H., and Tunalı, Y., Arch. Pharm. (Weinheim), 2013, vol. 346, no. 6, p. 463. https://doi.org/10.1002/ardp.201200479
Ismail, A.H., Abdula, A.M., Tomi, I.H.R., AlDaraji, A.H.R., and Baqi, Y., Med. Chem., 2021, vol. 17, no. 5, p. 462. https://doi.org/10.2174/1573406415666191107121757
Evranos Aksöz, B., Gürpinar, S.S., and Eryilmaz, M., Turk. J. Pharm. Sci., 2020, vol. 17, no. 5, p. 500. https://doi.org/10.4274/tjps.galenos.2019.42650
Lokesh, B.V.S., Prasad, Y.R., and Shaik, A.B., Infect. Disord.: Drug Targets, 2019, vol. 19, no. 3, p. 310. https://doi.org/10.2174/1871526519666181217120626
Jayaprakash, V., Sinha, B.N., Ucar, G., and Ercan, A., Bioorg. Med. Chem. Lett., 2008, vol. 18, no. 24, p. 6362. https://doi.org/10.1016/j.bmcl.2008.10.084
Ali, M.A., Yar, M.S., Kumar, M., and Pandian, G.S., Nat. Prod. Res., 2007, vol. 21, no. 7, p. 575. https://doi.org/10.1080/14786410701369367
Wong, K.T., Osman, H., Parumasivam, T., Supratman, U., Che Omar, M.T., and Azmi, M.N., Molecules, 2021, vol. 26, no. 7, article no. 2081. https://doi.org/10.3390/molecules26072081
Li, Q.S., Shen, B.N., Zhang, Z., Luo, S., and Ruan, B.F., Curr. Med. Chem., 2021, vol. 28, no. 5, p. 940. https://doi.org/10.2174/0929867327666200306120151
Song, Y., Feng, S., Feng, J., Dong, J., Yang, K., Liu, Z., and Qiao, X., Eur. J. Med. Chem., 2020, vol. 200, article ID 112459. https://doi.org/10.1016/j.ejmech.2020.112459
Xu, C.-J. and Shi, Y.-Q., J. Chem. Crystallogr., 2011, vol. 41, p. 1816. https://doi.org/10.1007/s10870-011-0178-4
Friesner, R.A., Murphy, R.B., Repasky, M.P., Frye, L.L., Greenwood, J.R., Halgren, T.A., Sanschagrin, P.C., and Mainz, D.T., J. Med. Chem., 2006, vol. 49, no. 21, p. 6177. https://doi.org/10.1021/jm051256o
Halgren, T.A., Murphy, R.B., Friesner, R.A., Beard, H.S., Frye, L.L., Pollard, W.T., and Banks, J.L., J. Med. Chem., 2004, vol. 47, no. 7, p. 1750. https://doi.org/10.1021/jm030644s
Friesner, R.A., Banks, J.L., Murphy, R.B., Halgren, T.A., Klicic, J.J., Mainz, D.T., Repasky, M.P., Knoll, E.H., Shelley, M., Perry, J.K., Shaw, D.E., Francis, P., and Shenkin, P.S., J. Med. Chem., 2004, vol. 47, no. 7, p. 1739. https://doi.org/10.1021/jm0306430
Vilchèze, C., Morbidoni, H.R., Weisbrod, T.R., Iwamoto, H., Kuo, M., Sacchettini, J.C., and Jacobs, W.R., Jr., J. Bacteriol., 2000, vol. 182, no. 14, p. 4059. https://doi.org/10.1128/JB.182.14.4059-4067.2000
ACKNOWLEDGMENTS
The authors are thankful to the M.G. Science Institute of Science and Department of Chemistry, Ahmedabad Gujarat University for providing research facilities. The authors also thank Schrödinger Inc. for providing GLIDE software to perform the molecular docking studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare the absence of conflict of interest.
Rights and permissions
About this article
Cite this article
Zala, M.J., Vora, J.J. & Khedkar, V.M. Synthesis and Molecular Docking Study of Arylsulfanyl Pyrazolylpyrazoline Derivatives as Antitubercular Agents. Russ J Org Chem 57, 2054–2062 (2021). https://doi.org/10.1134/S107042802112023X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S107042802112023X